Areas of expertise: Immunotherapy, oncology, infectious disease, autoimmune disease, corporate planning, strategic planning, M&A, capital raising.
Current role: CEO and Co-founder, Wyvern Pharmaceuticals Inc., and Kickshaw Ventures Ltd.
Mr. Thompson has been involved with biotechnology ventures for 39 years, including 23 years as CEO of two NASDAQ listed biotech companies. He has founded and cofounded 18 biotech companies, of which nine went on to be publicly listed, and five that were acquired by other companies. His areas of interest have been in autoimmune disease, oncology, and infectious disease. He is a well-known life sciences professional with nearly 40 years of experience in the sector, gained in academia, government research and industry. Brad has been a regular participant in business partnering having assessed and responded to thousands of partnering requests from first contact evaluations to due-dilligence evaluations and deal negotiations, and managing the resultant R&D collaborations.